Certain Abbott blood sugar monitors may give incorrect readings
Jul 26, 2024
“Abbott has recently identified a small number of FreeStyle Libre 3 sensors that may provide incorrect high glucose readings, which if undetected may pose a potential health risk for people living...
New report calls for more research on women’s health issues
Jul 12, 2024
The National Academies of Sciences, Engineering and Medicine analysis noted that women are disproportionately affected by chronic illnesses, including Alzheimer’s disease, depression and osteoporosis.
American Diabetes Association, June 21-24
Jul 01, 2024
The annual meeting of the American Diabetes Association was held this year from June 21 to 24 in Orlando, Florida, drawing more than 15,000 participants from around the world, including clinicians, academicians,...
Endocrine Society, June 1-4
Jun 20, 2024
The conference highlighted recent advances in the diagnosis and management of obesity, endocrine disorders, diabetes, and growth hormone and thyroid diseases.
More than 200 insulin pump users injured after app causes malfunction
May 09, 2024
The US Food and Drug Administration has issued a Class 1 recall — its most urgent kind — for an IOS app linked to a specific kind of insulin pump used by people with diabetes.
Diabetes increases risk for functional limitations in older adults
May 03, 2024
The findings were seen even after controlling for sociodemographic and other health factors.
Coverage for Medicare’s e-visits still available, though few patients use service
By
Kristen Fischer
Apr 16, 2024
E-visits, which drew expanded coverage during the pandemic still are available but not used often, a new study shows.
RPM landscape in 2024: centralized care teams required to realize potential of monitoring tech, experts...
By
Aaron Dorman
Feb 15, 2024
Having care teams solely dedicated to RPM data will both address patient needs and avoid “alert fatigue,” a new report suggests.
First OTC continuous blood glucose monitor cleared for marketing by FDA
Mar 06, 2024
The Dexcom Stelo Glucose Biosensor System is intended for people aged 18 or more years who have type 2 diabetes but do not take insulin.
Disease knowledge limited among individuals with type 2 diabetes
Mar 13, 2024
The item with lowest percentage of correct answers (4.4%) was related to identification of signs of ketoacidosis.